➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Express Scripts
Baxter
Harvard Business School

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Diflucan In Sodium Chloride 0.9% In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00189709 Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia Completed Astellas Pharma Taiwan, Inc. Phase 3 2004-08-01 To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia
NCT00189709 Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia Completed Astellas Pharma Inc Phase 3 2004-08-01 To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia
NCT00350818 Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) Completed Celgene Corporation Phase 1 2005-10-01 Primary Objective: -To determine the dose and schedule combination of 5-Azacitidine, when used as maintenance treatment after allogeneic transplantation for high-risk AML / MDS. Secondary Objective: -To assess the effect of treatment on survival after allogeneic transplantation for high-risk AML / MDS.
NCT00350818 Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) Completed M.D. Anderson Cancer Center Phase 1 2005-10-01 Primary Objective: -To determine the dose and schedule combination of 5-Azacitidine, when used as maintenance treatment after allogeneic transplantation for high-risk AML / MDS. Secondary Objective: -To assess the effect of treatment on survival after allogeneic transplantation for high-risk AML / MDS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diflucan In Sodium Chloride 0.9% In Plastic Container

Condition Name

Condition Name for Diflucan In Sodium Chloride 0.9% In Plastic Container
Intervention Trials
Healthy 3
Candidiasis 3
Bioequivalence 2
Crohn Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Diflucan In Sodium Chloride 0.9% In Plastic Container
Intervention Trials
Candidiasis 5
Mycoses 3
Leukemia 2
Vaginitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Diflucan In Sodium Chloride 0.9% In Plastic Container

Trials by Country

Trials by Country for Diflucan In Sodium Chloride 0.9% In Plastic Container
Location Trials
United States 22
Canada 3
Switzerland 2
Nigeria 1
Kenya 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Diflucan In Sodium Chloride 0.9% In Plastic Container
Location Trials
New York 2
North Carolina 2
Minnesota 2
Texas 2
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Diflucan In Sodium Chloride 0.9% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Diflucan In Sodium Chloride 0.9% In Plastic Container
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 2
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Diflucan In Sodium Chloride 0.9% In Plastic Container
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 4
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Diflucan In Sodium Chloride 0.9% In Plastic Container

Sponsor Name

Sponsor Name for Diflucan In Sodium Chloride 0.9% In Plastic Container
Sponsor Trials
Pfizer 3
Dr. Reddy's Laboratories Limited 2
Agency for Healthcare Research and Quality (AHRQ) 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Diflucan In Sodium Chloride 0.9% In Plastic Container
Sponsor Trials
Other 16
Industry 13
NIH 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Johnson and Johnson
Moodys
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.